HH

Hamid R. Hoveyda

OS Ogeda Sa: 22 patents #1 of 10Top 10%
TP Tranzyme Pharma: 15 patents #1 of 19Top 6%
OT Ocera Therapeutics: 5 patents #8 of 37Top 25%
ET Epics Therapeutics: 4 patents #1 of 18Top 6%
ES Euroscreen S.A.: 3 patents #23 of 56Top 45%
UC University Of British Columbia: 3 patents #199 of 1,308Top 20%
Overall (All Time): #49,040 of 4,157,543Top 2%
53
Patents All Time

Issued Patents All Time

Showing 1–25 of 53 patents

Patent #TitleCo-InventorsDate
12162849 Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deuterated form thereof Guillaume Dutheuil 2024-12-10
11731974 N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists Guillaume Dutheuil, Graeme L. Fraser 2023-08-22
11478472 NK-3 receptor antagonists for therapeutic treatment of leptin-related disease Graeme L. Fraser 2022-10-25
11078203 Deuterated fezolinetant 2021-08-03
11072582 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2021-07-27
10941151 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Guillaume Dutheuil, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt 2021-03-09
10836768 N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists Guillaume Dutheuil, Graeme L. Fraser 2020-11-17
10787458 Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines Guillaume Dutheuil 2020-09-29
10781171 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2020-09-22
10683295 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Guillaume Dutheuil, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt 2020-06-16
10624890 NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat Graeme L. Fraser 2020-04-21
10577318 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2020-03-03
10544150 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Marie-Odile Roy, Graeme L. Fraser, Guillaume Dutheuil 2020-01-28
10358416 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2019-07-23
10258602 Macrocyclic ghrelin receptor modulators and methods of using the same Graeme L. Fraser, Kamel Benakli, Eric Marsault, Mark L. Peterson 2019-04-16
10214533 N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders Guillaume Dutheuil, Graeme L. Fraser 2019-02-26
10183948 N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists Guillaume Dutheuil, Graeme L. Fraser 2019-01-22
10065960 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Marie-Odile Roy, Graeme L. Fraser, Guillaume Dutheuil 2018-09-04
10065961 Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Guillaume Dutheuil, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt 2018-09-04
10040751 Intermediates for macrocyclic compounds Eric Marsault, Kamel Benakli, Mark L. Peterson, Sylvie Beaubien, Luc Ouellet +2 more 2018-08-07
10030025 Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists Guillaume Dutheuil, Graeme L. Fraser 2018-07-24
10017468 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2018-07-10
9987274 N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists Guillaume Dutheuil, Graeme L. Fraser 2018-06-05
9969745 N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders Guillaume Dutheuil, Graeme L. Fraser 2018-05-15
9969738 N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders Guillaume Dutheuil, Graeme L. Fraser 2018-05-15